|
 |
|
|
| |
|
Newsletter Sponsor
|
|
White Paper: Risk Assessment for Single-Use Pharmaceutical Manufacturing Systems
To help ensure patient safety, biopharmaceutical companies must identify possible risks and mitigate exposure to those risks.
This white paper provides insights into current and expected industry and regulatory requirements for single-use manufacturing systems, e.g. more detailed extractables and material qualification data. It also reviews quality and regulatory documentation based on these requirements, which will make risk assessments more efficient.
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
